|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 98, 434-442, Copyright © 1989 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
JP Mashburn, GJ Kontos Jr, K Hashimoto, DM Wilson and HV Schaff
The autoperfused working heart-lung preparation has been used for extended
cardiopulmonary preservation for transplantation. However, acute lung
injury and failure of the preparation can result from pulmonary
hypertension, which previous investigators have linked to denervation. We
studied the neural and vasoactive mediators of pulmonary vasoconstriction
during normothermic autoperfusion of the heart and lungs from 13 calves.
Pulmonary vascular resistance was quantitated by multipoint pulmonary
artery pressure/flow plots generated by incremental reduction in venous
return at three times: A, after sternotomy but before autoperfusion
(control); B, during in situ autoperfusion (innervated heart-lung
preparation); and C, after explanation (denervated heart-lung preparation).
During hemodynamic measurements, left atrial blood samples were obtained
for measurement of thromboxane B2, 6-keto-prostaglandin-F1 alpha, and
complement activation products C3a and C5a. Results show that pulmonary
hypertension in the autoperfused working heart-lung preparation begins
during autoperfusion before denervation and may be related to complement
activation and to increased levels of circulating thromboxane B2 and
6-keto-prostaglandin F1 alpha (both the absolute levels and the ratio of
thromboxane B2 to 6-keto-prostaglandin F1 alpha). After denervation, both
prostaglandin intermediates were markedly increased, but their ratio was
not significantly affected. These data suggest that there is an initial
stage of pulmonary vasoconstriction at the onset of autoperfusion that is
accompanied by increased circulating levels of vasoactive mediators and
that denervation further contributes to this response.
ARTICLES
The role of neural and vasoactive mediators in the regulation of the pulmonary circulation during cardiopulmonary preservation
Mayo Clinic, Rochester, MN 55905.
This article has been cited by other articles:
![]() |
A. Serraf, M. Robotin, N. Bonnet, H. Detruit, B. Baudet, M. G. Mazmanian, P. Herve, and C. Planche ALTERATION OF THE NEONATAL PULMONARY PHYSIOLOGY AFTER TOTAL CARDIOPULMONARY BYPASS J. Thorac. Cardiovasc. Surg., December 1, 1997; 114(6): 1061 - 1069. [Abstract] [Full Text] |
||||
![]() |
K. Morita, K. Ihnken, G. D. Buckberg, M. P. Sherman, and L. J. Ignarro Pulmonary Vasoconstriction Due to Impaired Nitric Oxide Production After Cardiopulmonary Bypass Ann. Thorac. Surg., June 1, 1996; 61(6): 1775 - 1780. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |